Lonza Closes Acquisition of amaxa

Lonza Group (SWX:Lonn) announces that it has completed the acquisiton of amaxa as of 2 July 2008. This deal significantly strengthens the Cell Discovery business of Lonza by complementing and expanding the existing portfolio.

Next Online User Webinar: Improving Nucleofection Experiments

Join our upcoming online user webinar and and get specific guidelines and the latest tips & hints on general experimental design, reporter gene assays, co-transfection, stable transfection and RNAi :

Date 1: Tuesday, Sep 16, 2008 10:00 A.M CET (Europe) / 5:00 P.M. JST (Japan)
Date 2: Wednesday, Sep 17, 2008 2:00 P.M. EST (US) / 11:00 A.M. PST (US)

New - High Throughput Nucleofection of Human Stem Cell Line H9

With the new Human Stem Cell (H9) 96-well Nucleofector Kit amaxa broadened its product portfolio for Human Stem Cells. The kit allows high performance Nucleofection on H9 cells in a 96-well format.

Read more ...

New 96-well Shuttle Movie

Watch the new 96-well Shuttle Movie featuring the whole nucleofection process on the 96-well Shuttle.